院外心脏骤停中骨内与静脉血管通路:随机对照试验的系统评价与Meta分析
该系统评价与Meta分析纳入4项随机对照试验、共9475例成人院外心脏骤停患者,比较骨内(IO)与静脉(IV)血管通路。主要终点生存(30天或出院时)在IO组6.6%与IV组6.9%之间无显著差异(OR 0.99,95%CI 0.84-1.18),良好神经结局亦无显著差异(4.7% vs 4.6%,OR 1.07,95%CI 0.88-1.30)。持续自主循环恢复率IO组数值上低于IV组(24.6% vs 27.0%,OR 0.92,95%CI 0.80-1.06),但未达统计学显著。IO通路首次尝试成功率更高(92.3% vs 62.3%,OR 6.18,95%CI 3.50-10.91),建立通路时间快15秒(MD -0.25,95%CI -0.48至-0.01)。
要点
- 成人院外心脏骤停中,IO与IV通路在生存(30天或出院时)上无显著差异:IO组6.6% vs IV组6.9%,OR 0.99(95%CI 0.84-1.18)。
- 良好神经结局IO组4.7% vs IV组4.6%,OR 1.07(95%CI 0.88-1.30),无显著差异。
- 持续自主循环恢复率IO组24.6% vs IV组27.0%,OR 0.92(95%CI 0.80-1.06),数值上较低但未达统计学显著。
- IO通路首次尝试成功率92.3% vs IV组62.3%,OR 6.18(95%CI 3.50-10.91),IO显著更高。
- 通路建立时间IO较IV快15秒:IO 11.03±5.57 min vs IV 11.35±6.16 min,MD -0.25(95%CI -0.48至-0.01)。
适用人群与场景
- 成人院外心脏骤停(OHCA)患者,比较骨内(IO)与静脉(IV)血管通路。
研究设计与关键结果
- 研究类型:随机对照试验的系统评价与Meta分析,纳入4项RCT、共9475例成人OHCA患者,检索PubMed、Embase和ClinicalTrials.gov。
- 主要终点生存(30天或出院时):IO组6.6% vs IV组6.9%,OR 0.99(95%CI 0.84-1.18),无显著差异。
- 良好神经结局:IO组4.7% vs IV组4.6%,OR 1.07(95%CI 0.88-1.30),无显著差异。
- 持续自主循环恢复(ROSC):IO组24.6% vs IV组27.0%,OR 0.92(95%CI 0.80-1.06),IO数值上较低但未达统计学显著。
- 首次尝试血管通路成功率:IO组92.3% vs IV组62.3%,OR 6.18(95%CI 3.50-10.91),IO显著更高。
- 从急救人员到达至建立通路时间:IO组11.03±5.57 min vs IV组11.35±6.16 min,MD -0.25(95%CI -0.48至-0.01),IO快15秒。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价与Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,IO通路首次尝试成功率更高且建立更快,但成人OHCA中IO与IV在生存或良好神经结局上无显著差异;持续ROSC在IO组数值上较低但未达统计学显著。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rapid and reliable vascular access is crucial during cardiopulmonary resuscitation for out-of-hospital cardiac arrest (OHCA). While intraosseous (IO) and intravenous (IV) access are used, their comparative effectiveness for patient outcomes remains uncertain.
METHODS: We searched PubMed, Embase, and ClinicalTrials.gov for RCTs comparing IO vs. IV access in adults with OHCA. The primary outcome was survival (30 days or until discharge), while secondary outcomes included sustained ROSC, favorable neurological outcome, successful first-attempt vascular access, and time from emergency medical service arrival to access. Pooled odds ratios (OR), mean differences (MD), and 95% confidence intervals (CI) were calculated.
RESULTS: Four RCTs with 9475 patients were included. No significant differences were found between IO and IV groups in survival (6.6% vs. 6.9%, OR 0.99, 95% CI 0.84-1.18) or favorable neurological outcome (4.7% vs. 4.6%, OR 1.07, 95% CI 0.88-1.30). The sustained ROSC rate was numerically, but not significantly, lower in IO vs. IV access (24.6% vs. 27.0%, OR 0.92, 95% CI 0.80-1.06). IO access had a higher first-attempt success rate (92.3% vs. 62.3%; OR 6.18, 95% CI 3.50-10.91) and was 15 s faster than IV for vascular access (IO: 11.03 ± 5.57, IV: 11.35 ± 6.16 min, MD - 0.25, 95% CI - 0.48 to - 0.01).
CONCLUSIONS: IO access had a higher first-attempt success rate and faster establishment than IV access, but no significant differences were found in survival or favorable neurological outcomes in adults with OHCA. Sustained ROSC was numerically lower with IO access than IV access, although the difference was not statistically significant.
参考来源
- Alilou S, Moskowitz A, Rashedi S, et al. Intraosseous versus intravenous vascular access in out-of-hospital cardiac arrest: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2025. PMID: 40108619. doi:10.1186/s13054-025-05362-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。